The Affiliated Hospital Of Xuzhou Medical University
Clinical trials sponsored by The Affiliated Hospital Of Xuzhou Medical University, explained in plain language.
-
CAR T-Cell trial for lupus and myositis pulled before starting
Disease control TerminatedThis study aimed to test a new type of cell therapy (called CAR T-cells) in people with severe lupus or inflammatory myopathy that did not get better with standard treatments. The therapy uses donor cells to target and destroy faulty immune cells. However, the study was withdrawn…
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Engineered immune cells take on autoimmune diseases
Disease control OngoingThis study tests a new treatment for people with lupus or scleroderma that hasn't improved with standard care. The treatment uses specially engineered immune cells from a healthy donor (called universal CAR T-cells) to target and destroy faulty immune cells. The goal is to contro…
Phase: NA • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 13:50 UTC
-
Heart attack patients get a closer look: MRI study aims to sharpen prognosis
Knowledge-focused OngoingThis study looks at whether a special heart MRI, done within a week of a heart attack, can help doctors better predict a patient's future health. Researchers will follow 2,000 adults for years to track serious heart events like another attack or heart failure. The goal is to lear…
Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC